Project Details
Description
Repurposing the Antiviral Drug, Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss
| Status | Active |
|---|---|
| Effective start/end date | 10/1/21 → 6/30/24 |
Funding
- THE UNIVERSITY OF UTAH
- CURES WITHIN REACH
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.